Scientists test 'Train & Attack' immune therapy for tough sarcoma
NCT ID NCT03725605
Summary
This study tested a two-step immunotherapy for people with advanced soft tissue sarcoma that had stopped responding to standard treatments. First, a drug called LTX-315 was injected into one tumor to help attract the patient's own immune cells. Then, those immune cells were collected, grown in large numbers in a lab, and put back into the patient to fight the cancer. The main goals were to see if this approach was safe and if it could help the immune system attack the tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Herlev Hospital
Copenhagen, DK-2730, Denmark
Conditions
Explore the condition pages connected to this study.